Upgrade to SI Premium - Free Trial

KALA BIO (KALA)

2.06 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/25 *Est.)

Latest Headlines

Form SCHEDULE 13G/A KALA BIO, Inc. Filed by: BAKER BROS. ADVISORS LP May 15, 2026 4:26 PM - SEC Filing Form 10-Q KALA BIO, Inc. For: Mar 31 May 15, 2026 3:31 PM - SEC Filing Form S-3 KALA BIO, Inc. May 7, 2026 5:25 PM - SEC Filing Form 8-K KALA BIO, Inc. For: May 07 May 7, 2026 4:09 PM - SEC Filing KALA BIO implements 1-for-50 reverse stock split effective May 8 May 7, 2026 9:00 AM - StreetInsider KALA BIO Announces Reverse Stock Split May 7, 2026 9:00 AM - Globe NewsWire Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments April 28, 2026 8:00 AM - Globe NewsWire Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine April 21, 2026 7:00 AM - Globe NewsWire Form 10-K KALA BIO, Inc. For: Dec 31 April 15, 2026 4:04 PM - SEC Filing Kala Bio hires Dr. Saeid Babaei to review clinical assets April 1, 2026 6:45 AM - StreetInsider Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities April 1, 2026 6:45 AM - StreetInsider Form NT 10-K KALA BIO, Inc. For: Dec 31 March 31, 2026 4:06 PM - SEC Filing KALA BIO launches commercial AI research platform for biotech March 30, 2026 8:47 AM - StreetInsider KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live March 30, 2026 8:45 AM - StreetInsider Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate March 18, 2026 9:00 AM - StreetInsider Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate March 18, 2026 8:17 AM - StreetInsider Form D KALA BIO, Inc. March 17, 2026 4:59 PM - SEC Filing Form 144 KALA BIO, Inc. Filed by: KOVEN ANDREW I March 17, 2026 4:22 PM - SEC Filing Form 144 KALA BIO, Inc. Filed by: Rosen Howard B March 12, 2026 5:41 PM - SEC Filing Form 144 KALA BIO, Inc. Filed by: Myers C. Daniel March 12, 2026 4:05 PM - SEC Filing Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents March 11, 2026 11:20 AM - StreetInsider AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative March 11, 2026 10:01 AM - StreetInsider Kala Bio plans to ship first AI agent within 14 days March 11, 2026 6:31 AM - StreetInsider Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates March 11, 2026 6:30 AM - StreetInsider Full Article List